Neuroinflammatory phenotype in early Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Neuroinflammatory phenotype in early Alzheimer's disease.

Neuroinflammatory phenotype in early Alzheimer's disease.

http://www.wikidata.org/entity/Q36629135

about

Neural stem/progenitor cells in Alzheimer's disease Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies Myeloid Extracellular Vesicles: Messengers from the Demented Brain Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains The role of inflammasome in Alzheimer's disease Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons Targeting neuroinflammation in Alzheimer's disease CD74-immunoreactive activated M1 microglia are shown late in the gerbil hippocampal CA1 region following transient cerebral ischemia.Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations.Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice.Peripherally triggered and GSK-3β-driven brain inflammation differentially skew adult hippocampal neurogenesis, behavioral pattern separation and microglial activation in response to ibuprofen.Post-mortem analysis of neuroinflammatory changes in human Alzheimer's disease.Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation.Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies.Sex Differences In Outcomes Of Ablation Of Atrial Fibrillation.Age-associated alterations in the time-dependent profile of pro- and anti-inflammatory proteins within the hippocampus in response to acute exposure to interleukin-1β.Microglial priming in neurodegenerative disease.Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity GSK-3β, a pivotal kinase in Alzheimer disease.Neuroprotective effects of geniposide on Alzheimer's disease pathology.Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update.Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury.Are inflammatory profiles the key to personalized Alzheimer's treatment?Key Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation.The roles of inflammation and immune mechanisms in Alzheimer's disease.

P2860

Q26738352-9A23E523-3492-4CDC-BBD2-EFC15D6DB664 Q26767289-F5FFCA9F-8630-444E-8F15-EA6411F3289B Q26767455-BDBD68AC-D4D4-4257-9C6A-6BF7794DD20B Q26796857-23DFCCCB-A8E0-426A-88FE-7D7B6378539A Q26996822-FFC8085E-6128-4103-90AD-FA599A302C6E Q27014919-6679818B-720C-4956-95DE-42EEE427195A Q27303481-5967A4EB-B134-4FE3-953A-F7D85AF0CCA9 Q27335309-D386142E-A8CE-4C0F-B5A4-6031AE9114B2 Q28078474-648FE66E-8F03-4D7D-9DFD-9FD3F3FC03A6 Q33702437-E8703BE3-027A-4887-977C-C5C85715794E Q33768246-3EDA73F2-A21C-4944-9D5B-C9557CA995A6 Q33813209-462969E8-EBB9-4CDD-8D36-B4FCD2AD2320 Q33895668-A46CA34D-CE0D-4BE4-9D0C-394918B83456 Q34026887-DEC37EB9-BB49-49C0-98A6-A1B1F2B71BA0 Q35150206-A6C46C35-2475-4A03-9FE7-5CA8887D0FF1 Q35519004-AAE9724A-60DF-4AA0-B306-4DCB7D003C75 Q35809944-E102EAEB-57EA-4017-B19A-99F88E7A17E9 Q36150463-363C8A8F-0723-4F3C-905B-E5ADE51E8F89 Q36174802-B71B6C49-87C4-4040-B337-81A0AA6B5CD3 Q36252619-72A2B37D-49BD-4940-9229-F5BB85C8CCF6 Q36595660-52D3D2A3-8B18-4D44-AB5F-CADE65B7D4B6 Q36767734-C0CF40A3-6378-443F-93CD-4B0561F2BC38 Q36997011-41010B91-CBB1-4C6A-BC53-7A3FFD8314FF Q37024041-565A7DC7-D0AC-4069-9EE1-038052FB4B94 Q37340312-B31EC404-D1AC-4F2B-8F5B-B9D7861FC4EC Q37469058-E60035CD-374B-4159-AF9A-2401A307AEAF Q37571941-70D081EE-1FB5-414F-8924-C360A8D42DAB Q38196699-2C1132E3-286E-4B06-9605-B09007CBE7DB Q38203788-689CB353-4BE4-4B2E-BF91-856BDD5FCF45 Q38218085-6590CE23-68D9-4652-897D-F4E810B9537C Q38423431-3318F26F-7012-4A38-819C-3F166D4C2404 Q38558744-14359FEA-53AC-47C1-B6B8-27E99CB06ADB Q38592069-60F65CC2-A24C-4F75-86AE-E4DFC3299951 Q38693735-485C25C3-EB82-41C4-93DB-C92EB7D83B2B Q38833716-83864963-0745-46BF-A4F7-6CC6A9B65B7C Q40097111-80E314EF-DF64-48FB-A46B-D22A26698FD1 Q40408767-7F2E7D67-E8CB-4499-9E47-F93A7145304E Q41537684-037D214A-C46C-448D-B451-977B6BC431A8 Q41605528-7F8B73E3-98B7-45BD-87CD-125D2A74A04F Q42656274-D846B25B-C658-457B-A2E5-298733BFBC40

P2860

Neuroinflammatory phenotype in early Alzheimer's disease.

http://www.wikidata.org/entity/Q36629135

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Neuroinflammatory phenotype in early Alzheimer's disease.

@ast

Neuroinflammatory phenotype in early Alzheimer's disease.

@en

type

label

Neuroinflammatory phenotype in early Alzheimer's disease.

@ast

Neuroinflammatory phenotype in early Alzheimer's disease.

@en

prefLabel

Neuroinflammatory phenotype in early Alzheimer's disease.

@ast

Neuroinflammatory phenotype in early Alzheimer's disease.

@en

P1433

Q36629135-62531CB4-F971-442A-B588-F811CF26DCFA

P1476

Q36629135-EB9738F3-3D31-47CD-BAB8-780C8A760694

P2093

Q36629135-02DDF2C4-B230-4807-94D7-089B94D035E3

Q36629135-266B116F-1034-46EF-8D4F-A0171B9483BF

Q36629135-39F5A9FA-0CEE-4F78-80E8-CA4966A145BC

Q36629135-DB75354A-55AB-4B50-9EA4-5E437FCDCC07

P2860

Q36629135-025AC6C3-5CF6-45D6-920A-6F4604853A8C

Q36629135-067EC36E-CD8C-4C1F-9D68-90B9444B2F61

Q36629135-14576493-657F-4FFC-932C-B38A8FF4B3FC

Q36629135-14B7D8EE-51CE-447D-BA76-F7684748821E

Q36629135-2477DAA0-6928-40C7-B3C3-27E71D634BE6

Q36629135-2A373E4C-7527-474F-88B5-4219C3592BF2

Q36629135-2BC43BEB-A352-4C67-812D-70F6338B42DC

Q36629135-2E4D1C4B-C0E4-4A71-86D2-3D158FBCD40B

Q36629135-30601ADD-CB3D-402F-B90B-0A918FB41D2D

Q36629135-3069B439-CCAB-4D29-A0E0-CE5D7E90A899

P304

Q36629135-8E2C975B-C8A3-4EDF-9136-4570A969092B

P31

Q36629135-5C838F4D-17B3-42A1-B72C-EAA796F8CA98

P356

Q36629135-3734EC3E-D13D-4C45-9F5C-046E6B7FC45C

P433

Q36629135-EE658397-D466-4E9C-96DC-430A9A4519BE

P478

Q36629135-72A17BD7-F6BF-4909-A7B4-4689391385DF

P577

Q36629135-86792DC2-96E6-4DEE-A6E8-7252AE09EA34

P698

Q36629135-89AE52B2-3287-4322-B0D2-723B04C3D002

P921

Q36629135-C51324F1-ADA2-4255-9B8B-72B5FC8CB631

P932

Q36629135-8472E09D-6C89-4B01-9E53-0680BB7AB1D7

P356

J.NEUROBIOLAGING.2012.09.012

P1433

Neurobiology of Aging

P1476

Neuroinflammatory phenotype in early Alzheimer's disease.

@en

P2093

Donna M Wilcock

http://www.w3.org/2001/XMLSchema#string

Frederick A Schmitt

http://www.w3.org/2001/XMLSchema#string

Peter T Nelson

http://www.w3.org/2001/XMLSchema#string

Tiffany L Sudduth

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the full spectrum of macrophage activation

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

“Mini-mental state”

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Inflammation and Alzheimer's disease

Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques

The chemokine system in diverse forms of macrophage activation and polarization

Alternative activation of macrophages: an immunologic functional perspective

The many faces of macrophage activation

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

P304

1051-1059

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2012.09.012

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23062700

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3579221

http://www.w3.org/2001/XMLSchema#string